Can Bimekizumab Match IL-23 Inhibitors for Drug Survival After IL-17 Inhibitor Failure in Psoriasis?
A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.
Retrospective single-center review of 80 HFrEF patients added SGLT2 inhibitors on stable guideline-directed therapy, with ...
Morning Overview on MSN
Some arthritis supplements sent patients to the clinic with side effects, a study found
Patients who took widely available joint supplements marketed for arthritis relief ended up in clinics and emergency ...
Nearly one-third of patients with NSCC have koilocytosis on histopathology, which is indicative of having HPV-positive status ...
A recent retrospective study published in the Indian Journal of Nephrology in January 2026 reveals that low-dose regional ...
Short- and long-term outcomes of multiple myeloma patients undergoing modern treatments proceeding to ASCT: A retrospective analysis. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting ...
A group of evaluation researchers at Clinical and Translational Science Award (CTSA) hubs are conducting retrospective case studies to evaluate the translational research process. Earlier this year, ...
Distal femur fractures carry high mortality risks in elderly patients, but a significant clinical gap remains in comparing ...
"Investing in innovation for underserved populations saves lives." October 19, 2021 -- In 2014, Dr. Umut Gurkan, associate professor in the Case Western Reserve University School of Engineering, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results